Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Tela Bio, Inc.
13G/A
Amendment 2
TELA · 872381108
|
4.8% |
8/14/2026
Event 6/30/2026
|
|||
| SilverArc Capital Management, LLC | 4.8% | ||||
| Devesh Gandhi | 4.8% | ||||
|
Kalvista Pharmaceuticals, Inc.
13G/A
Amendment 2
483497AA1
|
0% |
8/14/2026
Event 6/30/2026
|
|||
| SilverArc Capital Management, LLC | 0% | ||||
| Devesh Gandhi | 0% | ||||
|
Elutia Inc.
13G/A
Amendment 2
ELUT · 05479K106
|
4.9% |
8/14/2026
Event 6/30/2026
|
|||
| SilverArc Capital Management, LLC | 4.9% | ||||
| Devesh Gandhi | 4.9% | ||||
|
Cellectar Biosciences Inc
13G
CLRB · 15117F880
|
10.0% |
8/14/2026
Event 6/30/2026
|
|||
| SilverArc Capital Management, LLC | 10.0% | ||||
| Devesh Gandhi | 10.0% | ||||
|
Tela Bio, Inc.
13G
TELA · 872381108
|
4.8% |
8/11/2026
Event 6/30/2026
|
|||
| SilverArc Capital Management, LLC | 4.8% | ||||
| Devesh Gandhi | 4.8% | ||||
|
Kalvista Pharmaceuticals, Inc.
13G
483497AA1
|
0% |
8/11/2026
Event 6/30/2026
|
|||
| SilverArc Capital Management, LLC | 0% | ||||
| Devesh Gandhi | 0% | ||||
|
Elutia Inc.
13G
ELUT · 05479K106
|
4.9% |
8/11/2026
Event 6/30/2026
|
|||
| SilverArc Capital Management, LLC | 4.9% | ||||
| Devesh Gandhi | 4.9% | ||||
|
NextCure, INC.
13G/A
Amendment 1
NXTC · 65343E207
|
4.9% |
5/13/2026
Event 3/31/2026
|
|||
| SilverArc Capital Management, LLC | 4.9% | ||||
| Devesh Gandhi | 4.9% | ||||
|
KalVista Pharmaceuticals Inc
13G
KALV · 483497103
|
5.6% |
5/13/2026
Event 3/31/2026
|
|||
| SilverArc Capital Management, LLC | 5.6% | ||||
| Devesh Gandhi | 5.6% | ||||
|
Helix Acquisition Corp. III
13G
HLXC · G4444S107
|
6.8% |
5/13/2026
Event 3/31/2026
|
|||
| SilverArc Capital Management, LLC | 6.8% | ||||
| Devesh S. Gandhi | 6.8% | ||||
|
Fractyl Health Inc
13G/A
Amendment 1
GUTS · 35168W103
|
2.3% |
5/13/2026
Event 3/31/2026
|
|||
| SilverArc Capital Management, LLC | 2.3% | ||||
| Devesh Gandhi | 2.3% | ||||
|
NextCure, INC.
13G
NXTC · 65343E207
|
5.0% |
2/12/2026
Event 12/31/2025
|
|||
| SilverArc Capital Management, LLC | 5.0% | ||||
| Devesh Gandhi | 5.0% | ||||
|
Avalo Therapeutics, Inc.
13G
AVTX · 05338F306
|
2.8% |
2/10/2026
Event 12/31/2025
|
|||
| SilverArc Capital Management, LLC | 2.8% | ||||
| Devesh Gandhi | 2.8% | ||||
|
iBio, Inc.
13G
IBIO · 451033708
|
10.0% |
11/14/2025
Event 9/30/2025
|
|||
| SilverArc Capital Management, LLC | 10.0% | ||||
| Devesh Gandhi | 10.0% | ||||
| SilverArc Capital Alpha Fund II, L.P. | 7.2% | ||||
|
Fractyl Health, Inc.
13G
GUTS · 35168W103
|
8.0% |
11/14/2025
Event 9/30/2025
|
|||
| SilverArc Capital Management, LLC | 8.0% | ||||
| Devesh Gandhi | 8.0% | ||||
|
Avalo Therapeutics, Inc.
13G
AVTX · 05338F306
|
5.5% |
11/14/2025
Event 9/30/2025
|
|||
| SilverArc Capital Management, LLC | 5.5% | ||||
| Devesh Gandhi | 5.5% | ||||
|
TELA Bio, Inc.
13G
TELA · 872381108
|
7.8% |
2/12/2025
Event 12/31/2024
|
|||
| SilverArc Capital Management, LLC | 7.8% | ||||
| Devesh S. Gandhi | 7.8% | ||||
|
Molecular Templates, Inc.
13G/A
Amendment 1
MTEM · 608550208
|
0% |
2/12/2025
Event 12/31/2024
|
|||
| SilverArc Capital Management, LLC | 0% | ||||
| Devesh S. Gandhi | 0% | ||||
|
Elutia Inc.
13G/A
Amendment 1
ELUT · 05479K106
|
5.9% |
2/12/2025
Event 12/31/2024
|
|||
| SilverArc Capital Management, LLC | 5.9% | ||||
| Devesh S. Gandhi | 5.9% | ||||